Inflation in the euro zone hit a two-year low a month after its economy began contracting, data showed on Tuesday, illustrating the dual impact of a steady diet of European Central Bank’s interest rate hikes.
British drugmaker GSK said on Tuesday it had signed a $1 billion agreement with Johnson & Johnson-owned Janssen for exclusive rights to further develop and commercialize the U.S.-based company’s hepatitis B therapy.
China Evergrande is trying to stave off liquidation by revising its debt restructuring plan, but its biggest challenge will be convincing its creditors, and shareholders in two of its units, that the proposal is worth their while.
Global index provider MSCI on Tuesday posted a higher third-quarter profit as product subscriptions benefited from a market recovery led by bets of the U.S. Federal Reserve easing up on rate hikes.
GE HealthCare Technologies Inc on Tuesday beat Wall Street expectations for third-quarter profit as a continued recovery in demand for surgical procedures boosted sales of its medical devices.
Vodafone will sell its Spanish business to Zegona Communications for 5 billion euros ($5.30 billion) in the second major deal by its new CEO to revamp a company struggling with little growth in mature markets.
Amgen , which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.
Lock maker Allegion beat estimates for third-quarter results and raised its annual profit forecast on Tuesday, on price hikes amid strong customer demand for its electronic security devices.
Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it recorded a hefty charge mainly from the U.S. government returning millions of doses of its antiviral treatment Paxlovid.
Marathon Petroleum beat estimates for third-quarter profit on Tuesday, as soaring demand for refined fuel amid already-tight supplies helped offset a decline in refining margins.